Sproutly Signs First Provincial Supply Agreement with Alberta

Sproutly Canada (CSE:SPR,OTCQB:SRUTF) announced on Tuesday (December 3) that its wholly-owned subsidiary, Toronto Herbal Remedies, has entered into a cannabis standing offer contract with the province of Alberta through Alberta Gaming, Liquor & Cannabis.

As quoted in the press release:

Pursuant to the Supply Agreement, Sproutly will supply AGLC with its indoor-grown dried flower products produced from THR, under the Company’s premium cannabis brand ‘CALIBER’. The Alberta Supply Agreement is the Company’s first executed provincial supply agreement for cannabis flower to date.

“Our Supply Agreement with AGLC marks the launch of our ‘CALIBER’ products to recreational consumers throughout one of the largest legal provincial markets in Canada by revenue, validating the demand of our products from customers and retailers across the country.” said Keith Dolo, CEO & Director of Sproutly. “With over 340 licensed physical cannabis retailers to date, the most out of any Canadian province, our partnership with AGLC will be a fantastic opportunity to seamlessly introduce our ‘CALIBER’ branded products in an established market, beginning with our premium dried flower portfolio. We look forward to replicating this success in additional markets across Canada”.

Click here to read the full press release.

Cannabis Free Report Cover

Find out what experts say about profiting from the cannabis market in 2021!

  
Read our FREE 2021 cannabis outlook report!
 

Aurora Cannabis Inc. Announces US$125 Million Bought Deal Financing

NYSE | TSX: ACB

Aurora Cannabis Inc. (“Aurora” or the “Company”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today has announced today that it has entered into an agreement with a syndicate of underwriters led by BMO Capital Markets and ATB Capital Markets, under which the underwriters have agreed to buy on bought deal basis 12,000,000 units of the Company (the “Units”), at a price of US$10.45 per Unit for gross proceeds of approximately US$125 million (the “Offering”). Each Unit will be comprised of one common share of the Company (a “Common Share”) and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a “Warrant”). Each Warrant will be exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering at an exercise price of US$12.60 per Warrant Share, subject to adjustment in certain events.

Keep reading... Show less

IIROC Trade Resumption – RVV

Trading resumes in:

Company: Revive Therapeutics Ltd.

Keep reading... Show less

Revive Therapeutics Announces Upsize to Previously Announced Bought Deal Offering

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES /

Revive Therapeutics Ltd. (” Revive ” or the ” Company “) (CSE:RVV) ( USA : RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it has entered into an amended agreement with Canaccord Genuity Corp. and Leede Jones Gable Inc. as the co-lead underwriters (collectively, the ” Underwriters “), to increase the size of its previously announced offering of units (the ” Equity Units “) at a price of $0.50 per Equity Unit. Under the amended terms, the Underwriters have agreed to purchase, on a bought deal basis, 40,000,000 Equity Units for gross proceeds to the Company of $20,000,000 (the ” Offering “). The over-allotment option granted to the Underwriters will proportionately increase to 15% of the Offering.

Keep reading... Show less

Trulieve Opens Location in Summerfield

The new dispensary brings expanded access for patients in the growing communities of Central Florida

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 77th nationwide. The new, 5,100 sq. ft. location marks the Company’s first in Summerfield expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

BioHarvest Sciences Inc. Announces Private Placement

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”).

The Company announced today that its board of directors have approved a private placement of up to 15,000,000 units at a price of $.40 per unit for gross proceeds of up to $6,000,000. Each unit will consist of one common share of the Company and one share purchase warrant. Each share purchase warrant will be exercisable to purchase an additional common share at a fixed price of $.45 per share for a period of one year from closing.

Keep reading... Show less